Achalasia: Outcome of patients treated with intrasphincteric injection of botulinum toxin

Gut

Volumn 41, Issue 1, 1997, Pages 87-92

  Cuilliere C ^a   Ducrotte P ^b   Zerbib, F ^c   Metman, E H ^d   De Looze, D ^l   Guillemot, F ^e   Hudziak, H ^f   Lamouliatte, H ^c   Grimaud, J C ^g   Ropert, A ^h   Dapoigny, M ⁱ   Bost, R ^j   Lemann M ^k   Bigard, M A ^f   Denis, P ^b   Auget, J L ^a   Galmiche, J P ^a   Des Varannes, S Bruley ^a,m  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c University Hospital Centre   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e Cardiology Hospital   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g Hospital and University Centre   (France)

^h RENNES UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^j GRENOBLE UNIVERSITY HOSPITAL   (France)

^k Hospital and University Centre   (France)

^l GHENT UNIVERSITY HOSPITAL   (Belgium)

^m CHU de Nantes   (France)

more..

Author keywords

Achalasia; Botulinum toxin; Oesophageal motor disorders

Indexed keywords

BOTULINUM TOXIN A; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC ECHOGRAPHY; EPIGASTRIC PAIN; ESOPHAGOGRAPHY; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; ESOPHAGUS SCINTISCANNING; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; THORAX PAIN; TREATMENT OUTCOME;

EID: 8544249874     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.1.87     Document Type: Article

References (27)

1. Katz PO. Achalasia. In: Castell DO, Richter J, Dalton C, eds. Esophageal motility testing. New York: Elsevier, 1987: 107-17.
2. Csendes A, Braghetto I, Henriquez A, Cortés C. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 1989; 30: 299-304.
3. Eckardt VF, Aignherr C, Bernhard G, Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103: 1732-8.
4. Lamouliatte H, Zerhib F, Bernard PH, Cayla R, Stablo M, Quinton A. Traitement par dilatation pneumatique des achalasies de l'œsophage [abstract]. Gastroenterol Clin Biol 1993; 17: A245.
5. Schwartz HM, Cahow CE, Traube M. Outcome after perforation sustained during pneumatic dilatation for achalasia. Dig Dis Sci 1993; 38: 1409-13.
6. Vantrappen G, Hellemans J. Treatment of achalasia and related motor disorders. Gastroenterology 1980; 79: 144-54.
7. Andreollo NA, Earlam RJ. Heller's myotomy for achalasia: is an added anti-reflux procedure necessary? Br J Surg 1987; 74: 765-9.
8. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl Med 1995; 332: 774-8.
9. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996; 110: 1410-5.
10. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Kalloo AN, Jones B, et al. Treatment of achalasia with intrasphincteric injection of botulinum toxin: a pilot trial. Ann Intern Med 1994; 121: 590-1.
11. Elston JS. The clinical use of botulinum toxin. Semin Ophtalmol 1988; 3: 249-60.
12. Poulain B. Mécanisme d'action moléculaire de la toxine tétanique et des neurotoxines botuliques. Pathol Biol 1994; 2: 173-82.
13. Jankovic J, Brin MF. Therapeutic uses of Botulinum toxin. N Engl J Med 1991; 324: 1186-94.
14. Pamphlett R. Early terminal and nodal sprouting of motor axons after botulinum toxin. J Neurol Sci 1989; 92: 181-92.
15. Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 1992; 56: 80-99.
16. MacKenzie I, Bumstock G, Dolly JO. The effects of purified botulinum neurotoxin type A on cholinergic adrenergic and non-adrenergic, atropine-resistant autonomic-neuromuscular transmission. Neuroscience 1982; 7: 997-1006.
17. Paul ML, Cook MA. Lack of effect of botulinum toxin on nonadrenergic, noncholinergic inhibitory response of the guinea pig fundus in vitro. Can J Physiol Pharmacol 1980; 58: 88-92.
18. Pasricha PJ, Ravich WJ, Kalloo AN. Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 1993; 105: 1045-9.
19. Devière J, Dunham F, Rickaert F, Bourgeois N, Cremer N. Endoscopic ultrasonography in achalasia. Gastroenterology 1989; 96: 1210-3.
20. Ziegler K, Zimmer T. The role of endoscopic ultrasonography in esophageal motility disorders. Endoscopy 1992; 24: 338-41.
21. Howard PJ, Maher L, Pryde A, Cameron EWJ, Heading RC. Five-year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992; 33: 1011-5.
22. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, et al. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc 1993; 68: 1067-73.
23. Jaïs F, Bruley des Varannes S, Simon J, Gasser P, Le Bodic L, Galmiche JP. La présentation clinique et la réponse thérapeutique des formes vigoureuses et non vigoureuses d'achalasie sont similaires [abstract]. Gastroenterol Clin Biol 1994; 18: A19.
24. Shoenut JP, Micflikier AB, Yaffe CS, Den Boer B, Teskey JM. Reflux in untreated achalasia patients. J Clin Gastroenterol 1995; 20: 6-11.
25. Kotfila R, Camp R, Trudeau W. Botulinum toxin (Botox) injection in achalasia patients failing pneumatic dilation and medical therapy [abstract]. Gastroenterology 1995; 108: A136.
26. Waterfall WE, Tougas G, Fachnie B, Chauhan U. Clinical and manometric response to Botulinum toxin (Botox) used as primary treatment for achalasia [abstract]. Gastroenterology 1995; 108: A255.
27. Kozarek RA, Gelfand MD, Patterson DJ, Brandabur JJ, Ball DJ, Bredfelt J, et al. Prospective trial of 50 vs 100 IU of type A Botulinum toxin for idiopathic achalasia [abstract]. Gastroenterology 1996; 110: A162.